Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3168795284;95285;95286 chr2:178546272;178546271;178546270chr2:179410999;179410998;179410997
N2AB3004690361;90362;90363 chr2:178546272;178546271;178546270chr2:179410999;179410998;179410997
N2A2911987580;87581;87582 chr2:178546272;178546271;178546270chr2:179410999;179410998;179410997
N2B2262268089;68090;68091 chr2:178546272;178546271;178546270chr2:179410999;179410998;179410997
Novex-12274768464;68465;68466 chr2:178546272;178546271;178546270chr2:179410999;179410998;179410997
Novex-22281468665;68666;68667 chr2:178546272;178546271;178546270chr2:179410999;179410998;179410997
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACT
  • RefSeq wild type template codon: TGA
  • Domain: Ig-152
  • Domain position: 67
  • Structural Position: 155
  • Q(SASA): 0.1759
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/I rs1471246687 -0.183 0.061 N 0.275 0.192 0.286848849266 gnomAD-2.1.1 4.02E-06 None None None None N None 0 2.9E-05 None 0 0 None 0 None 0 0 0
T/I rs1471246687 -0.183 0.061 N 0.275 0.192 0.286848849266 gnomAD-4.0.0 2.73694E-06 None None None None N None 0 2.23614E-05 None 0 0 None 0 0 2.69854E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.1069 likely_benign 0.1057 benign -1.163 Destabilizing 0.826 D 0.464 neutral N 0.465597297 None None N
T/C 0.3094 likely_benign 0.2981 benign -0.836 Destabilizing 0.1 N 0.385 neutral None None None None N
T/D 0.5747 likely_pathogenic 0.5891 pathogenic -1.173 Destabilizing 0.997 D 0.571 neutral None None None None N
T/E 0.3961 ambiguous 0.4024 ambiguous -1.018 Destabilizing 0.997 D 0.565 neutral None None None None N
T/F 0.2446 likely_benign 0.2394 benign -0.996 Destabilizing 0.991 D 0.587 neutral None None None None N
T/G 0.319 likely_benign 0.3199 benign -1.544 Destabilizing 0.969 D 0.551 neutral None None None None N
T/H 0.2571 likely_benign 0.2561 benign -1.739 Destabilizing 0.999 D 0.597 neutral None None None None N
T/I 0.1073 likely_benign 0.1077 benign -0.184 Destabilizing 0.061 N 0.275 neutral N 0.479530838 None None N
T/K 0.2821 likely_benign 0.2879 benign -0.494 Destabilizing 0.997 D 0.566 neutral None None None None N
T/L 0.0954 likely_benign 0.0942 benign -0.184 Destabilizing 0.759 D 0.456 neutral None None None None N
T/M 0.085 likely_benign 0.0837 benign -0.084 Destabilizing 0.991 D 0.582 neutral None None None None N
T/N 0.1758 likely_benign 0.1796 benign -1.018 Destabilizing 0.996 D 0.548 neutral N 0.478132144 None None N
T/P 0.875 likely_pathogenic 0.8799 pathogenic -0.479 Destabilizing 0.996 D 0.571 neutral N 0.501098245 None None N
T/Q 0.2386 likely_benign 0.2421 benign -0.925 Destabilizing 0.997 D 0.589 neutral None None None None N
T/R 0.2037 likely_benign 0.2024 benign -0.613 Destabilizing 0.997 D 0.574 neutral None None None None N
T/S 0.1298 likely_benign 0.1273 benign -1.283 Destabilizing 0.959 D 0.525 neutral N 0.453787031 None None N
T/V 0.0979 likely_benign 0.0958 benign -0.479 Destabilizing 0.079 N 0.171 neutral None None None None N
T/W 0.6097 likely_pathogenic 0.6064 pathogenic -1.054 Destabilizing 0.999 D 0.627 neutral None None None None N
T/Y 0.2835 likely_benign 0.2798 benign -0.701 Destabilizing 0.997 D 0.593 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.